- Популярные видео
- Авто
- Видео-блоги
- ДТП, аварии
- Для маленьких
- Еда, напитки
- Животные
- Закон и право
- Знаменитости
- Игры
- Искусство
- Комедии
- Красота, мода
- Кулинария, рецепты
- Люди
- Мото
- Музыка
- Мультфильмы
- Наука, технологии
- Новости
- Образование
- Политика
- Праздники
- Приколы
- Природа
- Происшествия
- Путешествия
- Развлечения
- Ржач
- Семья
- Сериалы
- Спорт
- Стиль жизни
- ТВ передачи
- Танцы
- Технологии
- Товары
- Ужасы
- Фильмы
- Шоу-бизнес
- Юмор
Built for Any Modality: Future-Proofing Manufacturing for Fast-Shifting Pipelines |PMWS26 Case Study
In this PMWS session, Anne Kantardjieff, VP and Head of CMC Development and Regulatory for Biologics and ATMPs at Biogen, explores how pharmaceutical manufacturers can build flexible, future-ready operations capable of supporting an increasingly diverse and rapidly evolving product pipeline.
As the industry expands beyond traditional biologics into advanced therapies, combination products, and new delivery formats, manufacturers must develop capabilities that are adaptable across modalities while maintaining speed, quality, and regulatory compliance. Kantardjieff shares a “modality-agnostic” approach to manufacturing and CMC readiness that enables organizations to launch at scale regardless of product type.
The session examines how companies can make strategic investments in facilities, technologies, and talent to reduce risk and accelerate commercialization timelines. Attendees will also gain insights into balancing internal capabilities with external partnerships, particularly when supporting differentiated product delivery models that require specialized manufacturing and supply chain strategies.
Key topics include:
- Future-proofing pharmaceutical manufacturing networks
- CMC development and manufacturing readiness across modalities
- Biologics, ATMPs, and advanced therapy manufacturing strategies
- Launch-at-scale planning and commercialization readiness
- Capital investment and technology prioritization in pharma manufacturing
- Workforce and capability development for emerging modalities
- Combination products and differentiated product delivery models
- Build-versus-partner manufacturing decisions
- Supply chain resilience and continuity planning
- Flexible manufacturing strategies for evolving pipelines
About PMWS:
The Pharma Manufacturing World Summit (PMWS) is a premier gathering of industry leaders, pharmaceutical manufacturing executives, and experts dedicated to exploring innovative strategies, emerging trends, and best practices in the evolving world of pharmaceutical manufacturing management. Through curated discussions and expert-led sessions, PMWS brings together manufacturing, quality, technical operations, and supply chain leaders to exchange insights, tackle industry challenges, and drive innovation across pharmaceutical production and operations.
Learn more at https://www.executiveplatforms.com/pmws/
Видео Built for Any Modality: Future-Proofing Manufacturing for Fast-Shifting Pipelines |PMWS26 Case Study канала Assemble Peer Intelligence
As the industry expands beyond traditional biologics into advanced therapies, combination products, and new delivery formats, manufacturers must develop capabilities that are adaptable across modalities while maintaining speed, quality, and regulatory compliance. Kantardjieff shares a “modality-agnostic” approach to manufacturing and CMC readiness that enables organizations to launch at scale regardless of product type.
The session examines how companies can make strategic investments in facilities, technologies, and talent to reduce risk and accelerate commercialization timelines. Attendees will also gain insights into balancing internal capabilities with external partnerships, particularly when supporting differentiated product delivery models that require specialized manufacturing and supply chain strategies.
Key topics include:
- Future-proofing pharmaceutical manufacturing networks
- CMC development and manufacturing readiness across modalities
- Biologics, ATMPs, and advanced therapy manufacturing strategies
- Launch-at-scale planning and commercialization readiness
- Capital investment and technology prioritization in pharma manufacturing
- Workforce and capability development for emerging modalities
- Combination products and differentiated product delivery models
- Build-versus-partner manufacturing decisions
- Supply chain resilience and continuity planning
- Flexible manufacturing strategies for evolving pipelines
About PMWS:
The Pharma Manufacturing World Summit (PMWS) is a premier gathering of industry leaders, pharmaceutical manufacturing executives, and experts dedicated to exploring innovative strategies, emerging trends, and best practices in the evolving world of pharmaceutical manufacturing management. Through curated discussions and expert-led sessions, PMWS brings together manufacturing, quality, technical operations, and supply chain leaders to exchange insights, tackle industry challenges, and drive innovation across pharmaceutical production and operations.
Learn more at https://www.executiveplatforms.com/pmws/
Видео Built for Any Modality: Future-Proofing Manufacturing for Fast-Shifting Pipelines |PMWS26 Case Study канала Assemble Peer Intelligence
pharmaceutical manufacturing Biogen manufacturing Anne Kantardjieff CMC development biologics manufacturing ATMP manufacturing advanced therapy manufacturing launch readiness pharma flexible manufacturing combination products pharmaceutical supply chain manufacturing strategy future of pharma manufacturing biotech operations pharmaceutical operations manufacturing scalability life sciences manufacturing PMWS pharmaceutical innovation
Комментарии отсутствуют
Информация о видео
2 июня 2026 г. 0:57:24
00:35:07
Другие видео канала




















